바이엘티

Pharmaceutical composition comprising inhibitor of LINC01419 expression as an active ingredient for preventingtreating hepatitis C virus infectious disease

Pharmaceutical composition comprising stimulator of expression of PWAR5 as an active ingredient for preventingtreating hepatitis C virus infectious disease

Oral Hepatitis C Virus Medicine

Composition for improvement, preventiontreatment of viral infection disease comprising phlorofucofuroeckol A as an active ingredient

Composition for improvementtreatment of viral infection disease comprising Diekol as an active ingredient

영문_국내특허